STROBE statement—Checklist of items that should be included in reports of observational studies:”Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries”.

Ruigómez, Ana; Schink, Tania; Voss, Annemarie; Herings, Ron M. C.; Smits, Elisabeth; Swart-Polinder, Karin; Balabanova, Yanina; Brobert, Gunnar; Suzart-Woischnik, Kiliana; Rodríguez, Luis Alberto García

doi:10.1371/journal.pone.0298596.s001

pone.0298596.s001.docx (34.35 kB)

STROBE statement—Checklist of items that should be included in reports of observational studies:”Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries”.

journal contribution

posted on 2024-03-07, 18:33 authored by Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M. C. Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

STROBE statement—Checklist of items that should be included in reports of observational studies:”Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries”.